RIGL Rigel Pharmaceuticals Inc. (New) PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

RIGL Stock Analysis: Buy, Sell, or Hold?

$44.00
+0.09 (+0.20%) ▲
5d: -14.21% 30d: -6.66% 90d: +7.87%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (68%)
Quality Score
58/100
Position
OVERSOLD
30-Day Fair Range
$44.95 – $50.50
Position: OVERSOLD
Forward P/E & Valuation
8.9x FAIR
vs 8.3x historical avg
Wall Street Target
$59.25
+34.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$37.60 / $52.61
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: RIGL shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Get Alerted When RIGL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$79.39
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$49.29
10.7% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.3x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: RIGL is currently trading at $44.00, which is considered oversold relative to its 30-day fair value range of $44.95 to $50.50. The stock's valuation (Forward PE: 8.9) is in line with its historical norms (8.3). At these levels, the market is pricing in 2.4% annual earnings growth.

Technical Outlook: Technically, RIGL is in a strong uptrend. Immediate support is located at $37.60, while resistance sits at $52.60.

Market Sentiment: RIGL scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $59.25 (+34.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $44.95 - $50.50
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 68.1%

Trading Range & Key Levels

30-Day Trading Range $44.95 - $50.50
Current vs Trading Range OVERSOLD
Expected Move (7 Days) ±$3.17 (7.2%)
Support Level $37.60
Resistance Level $52.61
Current Trend Strong Uptrend
Technical data as of Nov 10, 2026

Protect Your Profits

Holding RIGL? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • BEARISH: Weak technical setup (39/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 34.9% below Wall St target ($59.25)
  • BULLISH: Expecting earnings turnaround to 2.4% growth with 16.5% revenue growth
  • CAUTION: 5-day price weakness (-14.2%) - monitor closely

Fundamental Context

Forward P/E (Next Year Est.) 8.94
Wall Street Target $59.25 (+34.9%)
Revenue Growth (YoY) 16.5%
Earnings Growth (YoY) -55.5%
Profit Margin 106.6%
Valuation Premium vs History +2.4% premium
PE vs Historical 8.9 vs 8.3 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +2.4% (market-implied from PE analysis)
1-Year Target $44.96 (+2%)
2-Year Target $46.04 (+5%)
3-Year Target $47.15 (+7%)
3-Yr Target (if PE normalizes) (PE: 9→8) PE COMPRESSION $43.77 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 37.1%) $251.45 (+473%)
Base: (SPY PE: 8.9, Growth: 37.1%) $113.19 (+158%)
Bear: (PE: 7.6, Growth: 37.1%) $96.21 (+119%)
📈 Valuation based on Current Earnings
Trailing PE: 2.62 | Current EPS (TTM): $16.07
Bull Case $23.13 (-47%)
Analyst growth -50.0%, PE expands to 2.9
Base Case $21.03 (-52%)
Market implied -50.0%, PE stable at 2.6
Bear Case $28.59 (-35%)
Severe decline -20.0%, PE contracts to 2.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share RIGL Analysis

Share this live RIGL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (RIGL)

Bearish 5 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
4 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages indicate a bullish sentiment towards $RIGL with some traders questioning financial forecasts and sharing positive analyst coverage. No recent news articles were available.
Key Retail Themes: Questions about financial forecasts Positive analyst coverage
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:58 AM ET
Data refreshes hourly during market hours. Next update: 9:58 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for RIGL.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$107 62 BUY
INSM
Insmed Inc
STRONG BUY
24 analysts
$194 41 HOLD
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
19 analysts
$689 55 HOLD
RZLT
Rezolute Inc
STRONG BUY
11 analysts
$10 72 BUY
IMNM
Immunome Inc
STRONG BUY
17 analysts
$35 47 HOLD

Advanced RIGL Option Strategies

Professional options setups generated by AI based on today's RIGL price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive RIGL Research Pages
RIGL Technical Chart RIGL Price Prediction RIGL Intrinsic Value DCF RIGL Earnings Date RIGL Investment Advisor RIGL Fair Price Analyzer RIGL Options Chain RIGL Options Advisor RIGL Options Analysis RIGL Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals